Becton Dickinson (BDX) Cash from Discontinued Operations (2009 - 2025)
Becton Dickinson (BDX) reported Cash from Discontinued Operations of 368000000.0 for Q2 2025, down 1050.0% year-over-year from 38736842.11 in Q2 2024, and down 200.0% quarter-over-quarter from 368000000.0 in Q1 2025.
Becton Dickinson (BDX) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends
Becton Dickinson (BDX) has 10 years of Cash from Discontinued Operations data on file, last reported at 368000000.0 in Q2 2025.
- Cash from Discontinued Operations for Q2 2025 came in at 368000000.0, down 1050.0% year-over-year; the trailing twelve-month figure through Mar 2025 was 336000000.0 (up 2340.0% YoY), and the FY2024 annual result was 46000000.0, down 4500.0% from the prior year.
- Cash from Discontinued Operations declined to 368000000.0 in Q2 2025 per BDX's latest filing, from 368000000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 368000000.0 in Q1 2025 and troughed at 368000000.0 in Q2 2025.
- A 5-year average of 43500000.0 and a median of 48000000.0 in 2021 frame the typical range for Cash from Discontinued Operations.
- On a YoY basis, Cash from Discontinued Operations climbed as much as 1050.0% in 2025 and fell as far as 1050.0% in 2025.
- A 5-year view of Cash from Discontinued Operations shows it stood at 144000000.0 in 2021, then gained by 6.94% to 154000000.0 in 2022, then tumbled by 109.09% to 14000000.0 in 2023, then sank by 128.57% to 32000000.0 in 2024, then tumbled by 1050.0% to 368000000.0 in 2025.
- Business Quant data shows BDX's Cash from Discontinued Operations at 368000000.0 in Q2 2025, 368000000.0 in Q1 2025, and 32000000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -368.00 Mn |
| Jun 30, 2025 | -368.00 Mn |
| Mar 31, 2025 | 368.00 Mn |
| Mar 31, 2025 | 368.00 Mn |
| Jun 30, 2024 | -32.00 Mn |
| Jun 30, 2024 | -32.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Mar 31, 2022 | 154.00 Mn |
| Mar 31, 2022 | 154.00 Mn |
| Dec 31, 2021 | 144.00 Mn |
| Dec 31, 2021 | 144.00 Mn |
| Sep 30, 2021 | 97.00 Mn |
| Sep 30, 2021 | 97.00 Mn |
| Sep 30, 2013 | -434.00 Mn |
| Sep 30, 2013 | -434.00 Mn |
| Jun 30, 2013 | 6.00 Mn |
| Jun 30, 2013 | 6.00 Mn |